Tarbox Family Office, Inc. Agios Pharmaceuticals, Inc. Transaction History

Tarbox Family Office, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$26.68 - $34.81 $586 - $765	-22 Closed	0 $0
Q2 2020 Jul 23, 2020	SELL	$34.45 - $53.48 $964 - $1,497	-28 Reduced 56.0%	22 $1,000
Q1 2020 Apr 30, 2020	BUY	$31.52 - $53.81 $693 - $1,183	22 Added 78.57%	50 $2,000
Q4 2019 Jan 31, 2020	BUY	$30.08 - $50.59 $842 - $1,416	28 New	28 $1,000
Q3 2019 Oct 25, 2019	SELL	$32.4 - $49.58 $745 - $1,140	-23 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$42.73 - $76.53 $299 - $535	7 Added 43.75%	23 $1,000
Q3 2017 Oct 19, 2017	BUY	$54.89 - $67.12 $878 - $1,073	16	16 $1,000

226

56.2M

275K

251K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $2.83B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.